LMAT Lemaitre Vascular Inc

Price (delayed)

$87.88

Market cap

$1.97B

P/E Ratio

57.44

Dividend/share

$0.6

EPS

$1.53

Enterprise value

$1.96B

LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, ...

Highlights
LMAT's net income has soared by 65% year-on-year and by 13% since the previous quarter
The EPS has soared by 63% YoY and by 13% from the previous quarter
The P/E is 41% more than the 5-year quarterly average of 42.0 and 25% more than the last 4 quarters average of 47.1
The company's debt rose by 14% YoY

Key stats

What are the main financial stats of LMAT
Market
Shares outstanding
22.45M
Market cap
$1.97B
Enterprise value
$1.96B
Valuations
Price to book (P/B)
6.36
Price to sales (P/S)
9.83
EV/EBIT
44.4
EV/EBITDA
36.52
EV/Sales
9.83
Earnings
Revenue
$199.89M
EBIT
$44.26M
EBITDA
$53.8M
Free cash flow
$33.04M
Per share
EPS
$1.53
Free cash flow per share
$1.48
Book value per share
$13.81
Revenue per share
$8.94
TBVPS
$11.08
Balance sheet
Total assets
$353.96M
Total liabilities
$45.45M
Debt
$18.88M
Equity
$308.5M
Working capital
$176.15M
Liquidity
Debt to equity
0.06
Current ratio
7.57
Quick ratio
5.17
Net debt/EBITDA
-0.14
Margins
EBITDA margin
26.9%
Gross margin
66.5%
Net margin
17%
Operating margin
20.4%
Efficiency
Return on assets
10%
Return on equity
11.5%
Return on invested capital
22.1%
Return on capital employed
13.5%
Return on sales
22.1%
Dividend
Dividend yield
0.68%
DPS
$0.6
Payout ratio
39.2%

LMAT stock price

How has the Lemaitre Vascular stock price performed over time
Intraday
-2.72%
1 week
3.01%
1 month
7.33%
1 year
37.81%
YTD
54.83%
QTD
6.81%

Financial performance

How have Lemaitre Vascular's revenue and profit performed over time
Revenue
$199.89M
Gross profit
$132.83M
Operating income
$40.71M
Net income
$33.95M
Gross margin
66.5%
Net margin
17%
LMAT's net income has soared by 65% year-on-year and by 13% since the previous quarter
The operating income has soared by 52% YoY and by 11% from the previous quarter
The company's net margin rose by 39% YoY and by 9% QoQ
The company's operating margin rose by 29% YoY and by 7% QoQ

Growth

What is Lemaitre Vascular's growth rate over time

Valuation

What is Lemaitre Vascular stock price valuation
P/E
57.44
P/B
6.36
P/S
9.83
EV/EBIT
44.4
EV/EBITDA
36.52
EV/Sales
9.83
The EPS has soared by 63% YoY and by 13% from the previous quarter
The P/E is 41% more than the 5-year quarterly average of 42.0 and 25% more than the last 4 quarters average of 47.1
LMAT's price to book (P/B) is 45% higher than its 5-year quarterly average of 4.5 and 42% higher than its last 4 quarters average of 4.6
The equity has grown by 13% YoY and by 3.6% from the previous quarter
The P/S is 56% above the 5-year quarterly average of 6.5 and 40% above the last 4 quarters average of 7.2
Lemaitre Vascular's revenue has increased by 18% YoY and by 3.3% from the previous quarter

Efficiency

How efficient is Lemaitre Vascular business performance
Lemaitre Vascular's return on assets has increased by 49% YoY and by 10% QoQ
The ROE has grown by 47% YoY and by 10% from the previous quarter
The ROS has grown by 36% YoY and by 8% from the previous quarter
LMAT's ROIC is up by 35% year-on-year and by 7% since the previous quarter

Dividends

What is LMAT's dividend history
DPS
$0.6
Dividend yield
0.68%
Payout ratio
39.2%
Recent dividends

Financial health

How did Lemaitre Vascular financials performed over time
LMAT's quick ratio is up by 19% QoQ and by 16% YoY
Lemaitre Vascular's current ratio has increased by 16% from the previous quarter and by 10% YoY
The company's debt is 94% lower than its equity
The company's debt rose by 14% YoY
The equity has grown by 13% YoY and by 3.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.